Results 111 to 120 of about 3,406 (225)

Utility of Harmonisation for Fixel-Based Metrics in Travelling Subjects and Alzheimer's Disease Data. [PDF]

Hum Brain Mapp
Zou R, Kamagata K, Mito R, Takabayashi K, Andica C, Uchida W, Guo S, Kitagawa T, Fujita S, Uematsu A, Maikusa N, Koike S, Aoki S, Alzheimer's Disease Neuroimaging Initiative.   +13 more
europepmc   +1 more source

The role of editorial boards in shaping scholarly communication: A large‐scale mapping of their composition and structure

Journal of the Association for Information Science and Technology, EarlyView.
Abstract Editorial boards play a central role in shaping scholarly communication by influencing what research is published and how disciplinary boundaries are defined. Despite their importance, large‐scale, systematic evidence on their composition and structure remains limited.
Evangelina Becerra‐Rodero, José Luis Ortega   +1 more
wiley   +1 more source

Prospective Open-Label Safety Study of Edaravone Dexborneol in Filipino Patients With Acute Ischemic Stroke. [PDF]

Brain Behav
Sabellano ZF, Pedregosa B, Batino LK, Navarro J.   +3 more
europepmc   +1 more source

Operationalizing BioSSbD: A safe‐and‐sustainable‐by‐design framework for biorefineries

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Biorefineries are central to the transition toward a circular bioeconomy; however, their increasing scale and technological heterogeneity, and the integration of biological, chemical, and thermochemical processes introduce complex challenges related to safety, sustainability, and operational reliability. Existing Safe‐and‐Sustainable‐by‐Design
Fernando Ramonet
wiley   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Compounding asymmetries in nucleic acid synthesis screening: policy pathways for strengthening global biosecurity governance. [PDF]

Front Bioeng Biotechnol
Zakaria S, Peresson S, Sharkey CM, Engel K.   +3 more
europepmc   +1 more source

A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials

British Journal of Clinical Pharmacology, EarlyView.
Patient‐reported outcomes (PROs) are essential for assessing clinical benefit and tolerability from the patient's perspective. In oncology trials, PRO data analysis often involves responder and time‐to‐event analyses, which depend on predefined thresholds to determine clinically meaningful change.
Anna Margarete Maria Thurner, Daniela Krepper, Micha Johannes Pilz, Lisa Marie Storz, Maike Thumfart, Johannes Maria Giesinger   +5 more
wiley   +1 more source

Measuring cancer equity globally: harmonising international rural-urban classifications for exploring cancer outcomes. [PDF]

Lancet Reg Health West Pac
Wright C, Riva S, Crichton M, Rodi H, Jongebloed H, Leigh L, Johnston EA, Bergin RJ, Chapman A, Alston L, Crawford-Williams F, Hart NH, Rhee J, Gao L, Gunn K, Gasper H, Ugalde A, Marshall S.   +17 more
europepmc   +1 more source

Cerebrospinal Fluid and Plasma Concentrations of Atogepant in Humans. [PDF]

Clin Transl Sci
Boinpally RR, Trugman JM.
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source